chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received the vaccine on 01/20/21.Patient reports on  01/21/21 started having myalgia throughout his body and fatigue. He had difficulty sleeping due to discomfort. Reports vomited x1 on 01/20/21. He reports that he noticed DOE on 01/21/21  and SOB with in one block of walking. Asthma wise: takes ventolin/combivent with no relief of symptoms. Reports he is specifically having pain in his lungs/pleuritic in nature worse with coughing/sneezing, went to the ER  on 01/22/21.Chest xray,EKG and blood work were done. Xray and,EkG were normal with blood work showing anemia. Treated with IV pain medication with relief and D/C home with advise to take Nebulizer at home.
Symptoms: Skin rash (exanthema) initially appeared on left arm on 4/27 (4th day after vaccination) and extended to upper back over the following 1 -2 days.  Eventually the skin rash appeared over both left and right arms as well as full back. No pain but itchy.  Syptom still persists as of today (4/29)  Hemorrhoid broke and blood came out (4/29). Time course: 4 - 5 days
Hotness; Not hungry; Fever; Tired; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Hotness), DECREASED APPETITE (Not hungry), PYREXIA (Fever) and FATIGUE (Tired) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING HOT (Hotness), DECREASED APPETITE (Not hungry), PYREXIA (Fever) and FATIGUE (Tired). At the time of the report, FEELING HOT (Hotness), DECREASED APPETITE (Not hungry), PYREXIA (Fever) and FATIGUE (Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported  No treatment information was specified
Patient received moderna vaccine on 2/2/21 and 3/4/21. COVID positive on 1/18/22. Patient complained of abdominal pain presentation associated with vomiting for duration of two days.  Patient also complained of shortness of breath with minimal cough. Patient was recently admitted for abscess adjacent to the colonic anastomosis had IR drainage and discharged to follow-up with surgery in a week. Vitals on admission were significant for desaturation to 80 on room air. Labs on admission significant for sodium of 129, bicarb of 16, pCO2 20, positive COVID. Chest x-ray significant for new infiltrate. Patient was admitted for COVID pneumonia versus aspiration. Treated with dexamethasone, remdesivir, and azithromycin and ceftriaxone. Chest pain 1/23/22. HS trop increased. NSTEMI. Cardiology  consulted.  Full-dose Lovenox in addition to ongoing aspirin Plavix. Plan  Was stress test/Catheterization .             Developed cardiac arrest on 01/25/2022 morning.  Coded 3 times.  After the 3rd code, family opted for comfort care.  Patient passed away at 08:26 AM
RED SPOTS DEVELOPED ALL OVER STOMACH, CHEST, SIDE OF BODY.   THEY APPEARED 1 WEEK AFTER VACCINE - THEY HAVE NOT GONE AWAY YET.   VISITING DR TOMORROW
This spontaneous report as received from a physician and from a support services director refers to a patient of unknown age and gender. No information regarding the patient's medical history or concurrent conditions was provided. On 21-APR-2015, the patient was vaccinated with an improperly stored dose of GARDASIL 9 0.5 ml injection (lot # K026246, expiry date 28-JAN-2017; dose and route of administration were not reported). There were no concomitant therapies reported. The dose of the vaccine was exposed to a temperature excursion (date unspecified), lasting for 88 hours, with the lowest recorded temperature of 34 degrees Fahrenheit (1.11 degrees Celsius). The vaccine was stored in a refrigerator. No adverse effects were reported. There was no product quality complaint involved, This is one of several reports received from the same reporter. Additional information has been requested.
Information has been received from a physician concerning his daughter (child) who on an unspecified date was vaccinated with a dose of VARIVAX (Merck) (lot # not reported). Subsequently the patient developed chicken pox. The patient had sought unspecified medical attention. At the time of reporting, the patient's outcome was unknown. This is one of several reports received from the same source. Additional information has been requested.
Information has been received from a mother regarding her 17 year old male, with an allergy to eggs, who on 03/03/98 was vaccinated with a second dose of MMR II. In approximately June 1998, the pt experienced seizures. In follow-up, the primary care physician's office assistant reported that the pt was vaccinated at another physician's office. The child was seen on 01/30/98 and 05/11/98 according to the office records. Additional info has been requested. Upon internal review, seizures are considered as other important medical event.
PALE; BLURRY VISION; DIZZINESS; TIGHT CHEST; SHORTNESS OF BREATH; NAUSEA; HEADACHE; This spontaneous report received from a consumer concerned a 62 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included high blood pressure.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1816022, and expiry: UNKNOWN) dose was not reported, administered on 25-JUN-2021 for prophylactic vaccination. No concomitant medications were reported.  On 28-JUN-2021, the subject experienced pale. On 28-JUN-2021, the subject experienced blurry vision. On 28-JUN-2021, the subject experienced dizziness. On 28-JUN-2021, the subject experienced tight chest. On 28-JUN-2021, the subject experienced shortness of breath. On 28-JUN-2021, the subject experienced nausea. On 28-JUN-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, pale, blurry vision, nausea, dizziness, tight chest, and shortness of breath. This report was non-serious.; Sender's Comments: V0: Medical assessment not required as per standard operating procedure as the case is assessed as Non-serious
mom states began vomiting 5MAY93 around 9AM has vomited still unable to keep liquid or food down; no other unusual sx; encourage mom to seek MD advise cont w/n/v;
12/27 presented to the emergency department due to complaint of shortness of breath.  The patient s has been having shortness of breath and chills and headaches for the past 3 days.  COVID + test. On ceftriaxone/zmax/ decadron  12/28 Stop ceftriaxone/zmax, Start remdesivir, cont decadron 12/29 The patient is on minimal oxygen.  If the patient is weaned off oxygen, we would recommend discharging patient.  12/31 Discharged 1/2 blood pressure was elevated. This made her anxious, reached 180 systolic. Her only notable symptom right now is a headache, and persistent cough from her COVID, she was just discharged from here 2 days previously. Kept overnight released 1/3.
Flu like symptoms that last for 3 days; headache; I wake with what feels like a hangover and typically it gets worse from there; Tension level headache; Patient could only imagine is what a migraine may feel like; This is a spontaneous report from a contactable consumer or other non-HCP (patient). A patient of an unspecified age and gender received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- UNKOWN) via an unspecified route of administration on 15Feb2021 as dose 1, single for COVID-19 immunization. Patient medical history included COVID-19 in Jan2021, was hospitalized from 18Jan2021 to 23Jan2021. Received the Remdesivir injections for 5 days and was discharged on an unspecified date in Jan2021. On 15Feb2021, patient received the first of 2 Pfizer covid-19 injections (the second on 10Mar2021). The next day, 16Feb2021 developed flu like symptoms that lasted 3 days. At the end of the 3 days most symptoms had gone away but still had daily reoccurring headaches on an unspecified date in Feb2021. It was now 6 months later and still had daily headaches. Many days the headache was almost debilitating. At best wake with what felt like a hangover and typically it got worse from there on an unspecified date in Feb2021. At best many of the hours in a day it felt like a bad hangover, progressing to what may be a tension level headache and maybe finishing with what patient could only imagine is what a migraine may feel like on an unspecified date in 2021. The treatment medications included Nortriptyline at bedtime, Nurtec, Zipsor, Ubrelvy and Ajovy injections. Zipsor when Nurtec or Ubrelvy did not help. Patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- UNKOWN) via an unspecified route of administration on 10Mar2021 as dose 2, single for COVID-19 immunization. Patient had an MRI, MRA and MRV of the brain with results as unspecified. Had MRI of the neck and spine with result as unspecified. A TMJ CT scan with result as unspecified and COVID-19 on an unspecified date in Jan2021. Seeing a neurologist but to date still had issues and did not see any light at the end of a very dark tunnel. The outcome of the events headache and feeling abnormal was not recovered, of the events tension headache and migraine was unknown, while of the event flu like symptoms was resolved on 19Feb2021.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.  Information about lot/batch number cannot be obtained. No further information expected.
22JAN & 23JAN felt weird;23JAN in the evening froze all night;24JAN had chills, sweating, h/a, sinus problems & mouth felt very sore like had burned it w/something hot;also had excess saliva & blister in mouth;to MD;MD stated rxn to shot;
This is a spontaneous report from a contactable consumer reporting for herself. A 72-year-old female patient received of PREVENAR 13 and Flu, both on 18Nov2015 at single dose. Medical history and concomitant medications were not provided. Patient took pneumonia vaccine in the past. The patient's arm was itchy and she had a little fever on an unknown date after the vaccination. She also had some tenderness and redness. Patient was hospitalized due to fever, tenderness and redness. The consumer was treated with acetaminophen for pruritus, no treatment given for fever, tenderness and redness. Events resolved on an unknown date.
exacerbation of her thyroid autoimmune condition; exacerbation of her thyroid autoimmune condition; fatigue; aches; weakness; Initial information received on 10-Aug-2021 regarding an unsolicited valid serious case from a consumer via Agency (Reference number- 00718199).  This case is linked to case 2021SA269884.  This case involves a 47 year old female patient who experienced exacerbation of her thyroid autoimmune condition (autoimmune thyroid disorder) and (condition aggravated), fatigue, aches (pain) and weakness (asthenia), while receiving vaccine DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL].  Medical treatment, vaccination, concomitant medication and family history were not provided.  At the time of the event, the patient had ongoing Autoimmune thyroid disorder.  On an unknown date, the patient received a dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE (lot number and expiry date: not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a serious fatigue, aches (pain), weakness (asthenia) and exacerbation of her thyroid autoimmune condition (autoimmune thyroid disorder) and (condition aggravated), (unknown latency) following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE. These events were assessed as medically significant.  Details of laboratory data not reported.  It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome of events were reported as unknown.  Information on the batch number was requested.; Sender's Comments: This case involves a 47 year old female patient who had autoimmune thyroid disorder, condition aggravated, fatigue, pain and asthenia, after receiving ADACEL. The time to onset is unknown. At the time of the event, the patient had ongoing autoimmune thyroid disorder. Additional information regarding patient's medical history, condition at the time of the events, lab data excluding other predisposing etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of a vaccine cannot be assessed.
Information has been received from the authors in published literature article. This report concerned an 8 year old female patient which concurrent  conditions included milk allergy and sickle cell anaemia. On an unknown date (reported as "7 years previously,") the patient received her first vaccination with an unspecified varicella virus vaccine live (oka/merck)(manufacturer unknown) (dose, route, lot number and expiry date were not reported) for prophylaxis. At that time, there were no adverse events experienced. Also, it was reported that, on an unknown date (reported as "2 years previously") the patient experienced shortness of breath shortly after receiving an injectable unspecified influenza vaccine. Later, on an unknown date, the patient received diphenhydramine before administration of her second dose of unspecified influenza vaccine, without complications. Later, on an unknown date, the patient received her second dose of varicella virus vaccine live (oka/merck)(manufacturer unknown) (dose, route, lot number and expiry date were not reported) for prophylaxis. Then, 15 minutes after vaccination, the patient had shortness of breath, sneezing, rhinorrhea, and diffuse erythema and, due to that, the patient  required oral diphenhydramine and she was sent to emergency room where she received epinephrine (anaphylactic reaction). It was unknown if the patient was hospitalized. After that, on an unknown date, she was discharged with a prescription of oral corticosteroids and instruction to follow up with an allergy clinic. Also, on an unknown date, the patient underwent a skin test, that was negative to hepatitis A and influenza vaccines and positive to gelatin. At the reporting time, the outcome of anaphylactic reaction was not reported. The reporter considered anaphylactic reaction to be related to VARIVAX. Upon internal review, the event anaphylactic reaction was considered to be a medically significant event.
experiencing swelling under his armpit which is extremely painful; experiencing swelling under his armpit which is extremely painful; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date Mar2022 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for Covid-19 Immunization, reaction(s): "he also experienced adverse reactions on the 1st and 2nd dose"; Bnt162b2 (Dose 2), for Covid-19 Immunization, reaction(s): "he also experienced adverse reactions on the 1st and 2nd dose". The following information was reported: SWELLING (non-serious), PAIN (non-serious) all with onset 2022, outcome "unknown" and all described as "experiencing swelling under his armpit which is extremely painful".  Additional information: Caller would like to report an adverse reaction for the covid-19 vaccine. He said that he took the booster shot last week and was currently experiencing swelling under his armpit which was extremely painful. He also mentioned that he also experienced adverse reactions on the 1st and 2nd dose but subsided.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Persistent hissing and ringing in my left ear from 21st April 2021. It has been more than two months but the sound has not gone away.
1. CORONAVIRUS COVID-19 PNEUMONIA, ACUTE HYPOXEMIC RESPIRATORY FAILURE: onset of symptoms was 11/8. Pt tested positive for COVID on 11/9. Presented on 11/17 with SOB and cough, found to be hypoxemic requiring 2-3 L supplemental oxygen. Started on decadron and remdesivir on admission with ppx subq lovenox. On day 2, pt reported improvement in SOB, which was still present with ambulation from bed to bathroom but improves quickly with rest. Had persistent dry cough. No fevers/chills. Nausea resolved. Appetite, sense of taste, and sense of smell improved. Was continued on remdesivir and decadron course. Subq lovenox dose was increased, per obesity dosing. Overnight, supplemental oxygen requirement improved to 1 L then up to 2 L by day 3. However, SOB at rest and with exertion resolved and SOB only occurred with excessive coughing. Walking pulse ox showed mild desat to 88-89% on RA with ambulation, which recovers with rest. Pt reported feeling well/close to baseline. Inflammatory labs showed improvement. Per shared decision making, pt was discharged home in stable condition with supplemental oxygen to be used prn at 1-2 L for SOB. Pt instructed to monitor SpO2 at home. For cough, pt was instructed to try honey and given tx for prn tessalon. Isolation/quarantine end date set for 11/29.
Colon cancer; Cramping with sit ups/ The crunches or sit-ups aggravated the mass in his colon, and this went on for 2-3 weeks; Aggravated the mass in his colon; Pain; This spontaneous case was reported by a consumer and describes the occurrence of Colon cancer in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COLON CANCER (seriousness criteria hospitalization and medically significant), MUSCLE SPASMS, MASS, and PAIN. The patient was hospitalized for 14 days due to COLON CANCER. The patient was treated with Surgery for Colon cancer. At the time of the report, COLON CANCER, MUSCLE SPASMS, MASS, and PAIN outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available) on an unknown date, Computerised tomogram (abnormal) CT scan showed the cancer.         No concomitant medications and treatment medications were provided.  This case concerns a 70-year-old, male patient with no previous relevant medical history reported, who experienced the unexpected even of colon cancer. The event occurred on an unknown number of days after the second dose of mRNA-1273. The rechallenge was not applicable since the events happened after the second dose. The benefit-risk relationship of mRNA-1273 is not affected by this report.
Pt. mom reported that patient developed a rash around injection sites on both legs every time he received the immunization.
"Strange" tongue sensation began approximately 10 minutes following vaccination. 5 minutes later, tongue swelling and difficulty swallowing began. Patient appeared flushed as well. 911 was called. One dose of Epipen was administered into right thigh, followed by 50mg of Benadryl injected into left deltoid. EMS arrived shortly after and took patient to hospital. She was given steroids, monitored, and discharged with a prescription for a Medrol dosepak.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70-year-old female patient (not pregnant) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown), in right arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Azithromyacine, reaction(s): "Known allergies: Azithromyacine". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
The patient is now 18 years old and never received the 3 rd dose; No other AE; This spontaneous report has been received from a physician, concerning a currently 18-year-old patient of unknown gender.       The patient's concurrent conditions, medical history and concomitant medication were not reported.  On an unknown date (reported as "at age of 15 years and 4 months"), the patient was vaccinated with first dose of  hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (anatomical location, lot number and expiration date were not reported) as prophylaxis.  Then, on unknown date (reported as "two months later") the patient received the second dose of  hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (anatomical location, lot number and expiration date were not reported) as prophylaxis. At the reporting time, the patient had never received the 3rd dose (inappropriate schedule of vaccine administration). No adverse event reported.
Consumer answered "Yes" when the computer program asked if they had received the Moderna COVID-19 Vaccine and experienced a side effect.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Consumer answered "Yes" when the computer program asked if they had received the Moderna COVID-19 Vaccine and experienced a side effect.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Consumer answered "Yes" when the computer program asked if they had received the Moderna COVID-19 Vaccine and experienced a side effect.). At the time of the report, VACCINATION COMPLICATION (Consumer answered "Yes" when the computer program asked if they had received the Moderna COVID-19 Vaccine and experienced a side effect.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medication was reported.   No treatment information was provided.   No laboratory data was provided
2 days, post vax, mother noted hives on both legs, not at site of injection. They were scattered on both legs but more on right leg, where Prevnar given. Seen here at 12:50, rash was gone.
Redness, swelling, induration and slight tenderness (L) arm - from shoulder to above elbow. Able to move arm.
Second dose of vaccine series given one month early, based on interval recommendations. No complaints or signs of symptoms at this time from patient.
4 seizure type episodes (including shaking, eyes rolling back for about 15-30 seconds long) after being moved out of bed - lasted 4 days Fever up to 102.5 -  lasted 5 days Could not stand - 8 days Body aches - 8 days Could not walk - 9 days Weakness - on going since vaccine Shaking - on going since vaccine